In the last three months, 6 analysts have published ratings on Albemarle ALB, offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 3 | 3 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 1 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 0 | 0 |
3M Ago | 0 | 3 | 0 | 0 | 0 |
Analysts have recently evaluated Albemarle and provided 12-month price targets. The average target is $122.33, accompanied by a high estimate of $170.00 and a low estimate of $96.00. Marking an increase of 1.94%, the current average surpasses the previous average price target of $120.00.
Breaking Down Analyst Ratings: A Detailed Examination
In examining recent analyst actions, we gain insights into how financial experts perceive Albemarle. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Peter Osterland | Truist Securities | Announces | Hold | $96.00 | - |
John Roberts | Mizuho | Lowers | Neutral | $105.00 | $110.00 |
Ben Kallo | Baird | Raises | Neutral | $103.00 | $79.00 |
Arun Viswanathan | RBC Capital | Raises | Outperform | $133.00 | $108.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $127.00 | $132.00 |
Colin Rusch | Oppenheimer | Lowers | Outperform | $170.00 | $171.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Albemarle. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Albemarle compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Albemarle's stock. This analysis reveals shifts in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Albemarle's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Albemarle analyst ratings.
Delving into Albemarle's Background
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Albemarle's Financial Performance
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Albemarle's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -41.37% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Albemarle's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -81.99%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Albemarle's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -13.07%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Albemarle's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -6.2%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Albemarle's debt-to-equity ratio is below the industry average. With a ratio of 0.45, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Understanding the Relevance of Analyst Ratings
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.